PacBio encourages investors to carefully consider its results under GAAP, as well as its supplemental non‐GAAP information and the reconciliation between these presentations, to more fully ...
Good afternoon and welcome to PacBio fourth quarter of 2024 earnings ... A copy of our earnings presentation is also available on the investors section of our website. With me today are Christian ...
Piper Sandler lowered the firm’s price target on PacBio (PACB) to $2 from $2.50 following quarterly results. The firm keeps a Neutral rating on the shares. See what stocks are receiving strong ...
Genomics company Pacific Biosciences of California (NASDAQ:PACB) will be announcing earnings results tomorrow after market hours. Here’s what investors should know. PacBio missed analysts ...
MENLO PARK, Calif., Feb. 14, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation ...
Hosted on MSN26d
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q4 2024 Earnings Call TranscriptPacific Biosciences of California ... A copy of our earnings presentation is also available on the Investors section of our website. With me today are Christian Henry, President and Chief ...
Good day. And welcome to the PacBio Fourth Quarter 2024 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results